Trial Profile
The impact of the associated symptoms of other LUTS by tadalafil administration to patients with BPH
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Jun 2021
Price :
$35
*
At a glance
- Drugs Tadalafil (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- 10 Jun 2021 Status changed from recruiting to completed.
- 06 Jun 2018 Status changed from not yet recruiting to recruiting.
- 16 Dec 2015 Status changed from not stated to not yet recruiting.